147 related articles for article (PubMed ID: 38474631)
1. Platinum(0)-η
Compagno N; Piccolo R; Bortolamiol E; Demitri N; Rizzolio F; Visentin F; Scattolin T
Molecules; 2024 Mar; 29(5):. PubMed ID: 38474631
[TBL] [Abstract][Full Text] [Related]
2. Rational Design of Palladium(II) Indenyl and Allyl Complexes Bearing Phosphine and Isocyanide Ancillary Ligands with Promising Antitumor Activity.
Bortolamiol E; Botter E; Cavarzerani E; Mauceri M; Demitri N; Rizzolio F; Visentin F; Scattolin T
Molecules; 2024 Jan; 29(2):. PubMed ID: 38257258
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, anticancer activity, and molecular docking of half-sandwich iron(II) cyclopentadienyl complexes with maleimide and phosphine or phosphite ligands.
Das S; Strachanowska M; Wadowski P; Juszczak M; Tokarz P; Kosińska A; Palusiak M; Rybarczyk-Pirek AJ; Wzgarda-Raj K; Vasudevan S; Chworos A; Woźniak K; Rudolf B
Sci Rep; 2024 Mar; 14(1):5634. PubMed ID: 38454122
[TBL] [Abstract][Full Text] [Related]
4. New glycoconjugation strategies for Ruthenium(II) arene complexes via phosphane ligands and assessment of their antiproliferative activity.
Iacopini D; Vančo J; Di Pietro S; Bordoni V; Zacchini S; Marchetti F; Dvořák Z; Malina T; Biancalana L; Trávníček Z; Di Bussolo V
Bioorg Chem; 2022 Sep; 126():105901. PubMed ID: 35671646
[TBL] [Abstract][Full Text] [Related]
5. Novel and Versatile Imine-N-Heterocyclic Carbene Half-Sandwich Iridium(III) Complexes as Lysosome-Targeted Anticancer Agents.
Yang Y; Guo L; Tian Z; Gong Y; Zheng H; Zhang S; Xu Z; Ge X; Liu Z
Inorg Chem; 2018 Sep; 57(17):11087-11098. PubMed ID: 30133276
[TBL] [Abstract][Full Text] [Related]
6. New platinum (II) complexes based on schiff bases: synthesis, specification, X-ray structure, ADMET, DFT, molecular docking, and anticancer activity against breast cancer.
Eslami Moghadam M; Hasanzadeh Esfahani M; Behzad M; Zolghadri S; Ramezani N; Azadi Y
J Biol Inorg Chem; 2023 Aug; 28(5):519-529. PubMed ID: 37452868
[TBL] [Abstract][Full Text] [Related]
7. Novel cis-[(NHC)
Rehm T; Rothemund M; Muenzner JK; Noor A; Kempe R; Schobert R
Dalton Trans; 2016 Oct; 45(39):15390-15398. PubMed ID: 27603959
[TBL] [Abstract][Full Text] [Related]
8. Anticancer C,N-cycloplatinated(II) complexes containing fluorinated phosphine ligands: synthesis, structural characterization, and biological activity.
Cutillas N; Martínez A; Yellol GS; Rodríguez V; Zamora A; Pedreño M; Donaire A; Janiak C; Ruiz J
Inorg Chem; 2013 Dec; 52(23):13529-35. PubMed ID: 24229419
[TBL] [Abstract][Full Text] [Related]
9. Palladium(II)-η
Scattolin T; Bortolamiol E; Visentin F; Palazzolo S; Caligiuri I; Perin T; Canzonieri V; Demitri N; Rizzolio F; Togni A
Chemistry; 2020 Sep; 26(51):11868-11876. PubMed ID: 32368809
[TBL] [Abstract][Full Text] [Related]
10. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and in-depth studies on the anticancer activity of novel palladacyclopentadienyl complexes stabilized by N-Heterocyclic carbene ligands.
Scattolin T; Caligiuri I; Mouawad N; El Boustani M; Demitri N; Rizzolio F; Visentin F
Eur J Med Chem; 2019 Oct; 179():325-334. PubMed ID: 31255929
[TBL] [Abstract][Full Text] [Related]
12. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
[TBL] [Abstract][Full Text] [Related]
13. Dinuclear gold(I) complexes based on carbene and diphosphane ligands: bis[2-(dicyclohexylphosphano)ethyl]amine complex inhibits the proteasome activity, decreases stem cell markers and spheroid viability in lung cancer cells.
Casagrande N; Borghese C; Corona G; Aldinucci D; Altaf M; Sulaiman AAA; Isab AA; Ahmad S; Peedikakkal AMP
J Biol Inorg Chem; 2023 Dec; 28(8):751-766. PubMed ID: 37955736
[TBL] [Abstract][Full Text] [Related]
14. Chelating Phosphine-N-Heterocyclic Carbene Platinum Complexes via Catalytic Asymmetric Hydrophosphination and Their Cytotoxicity Toward MKN74 and MCF7 Cancer Cell Lines.
Seah JWK; Lee JXT; Li Y; Pullarkat SA; Tan NS; Leung PH
Inorg Chem; 2021 Nov; 60(22):17276-17287. PubMed ID: 34709031
[TBL] [Abstract][Full Text] [Related]
15. Cytotoxic and antiparasitic activities of diphosphine-metal complexes of group 10 containing acylthiourea as ligands.
de Oliveira TD; Ribeiro GH; Honorato J; Leite CM; Santos ACDS; Silva ED; Pereira VRA; Plutín AM; Cominetti MR; Castellano EE; Batista AA
J Inorg Biochem; 2022 Sep; 234():111906. PubMed ID: 35759891
[TBL] [Abstract][Full Text] [Related]
16. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of new allyl palladium complexes bearing purine-based NHC ligands with antiproliferative and proapoptotic activities on human ovarian cancer cell lines.
Scattolin T; Caligiuri I; Canovese L; Demitri N; Gambari R; Lampronti I; Rizzolio F; Santo C; Visentin F
Dalton Trans; 2018 Oct; 47(38):13616-13630. PubMed ID: 30207339
[TBL] [Abstract][Full Text] [Related]
18. Neutral and charged phosphine/scorpionate copper(I) complexes: effects of ligand assembly on their antiproliferative activity.
Porchia M; Dolmella A; Gandin V; Marzano C; Pellei M; Peruzzo V; Refosco F; Santini C; Tisato F
Eur J Med Chem; 2013 Jan; 59():218-26. PubMed ID: 23229057
[TBL] [Abstract][Full Text] [Related]
19. Platinum(II) complexes of imidazophenanthroline-based polypyridine ligands as potential anticancer agents: synthesis, characterization, in vitro cytotoxicity studies and a comparative ab initio, and DFT studies with cisplatin, carboplatin, and oxaliplatin.
Alexander C; Nithyakumar A; Paul MWB; Arockia Samy N
J Biol Inorg Chem; 2018 Jul; 23(5):833-848. PubMed ID: 29934700
[TBL] [Abstract][Full Text] [Related]
20. (C^N
Williams M; Green AI; Fernandez-Cestau J; Hughes DL; O'Connell MA; Searcey M; Bertrand B; Bochmann M
Dalton Trans; 2017 Oct; 46(39):13397-13408. PubMed ID: 28945262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
